Browsing by Author Garon, Edward B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 6 of 6
TitleAuthor(s)Issue Date
 
Five-year overall survival for patients with advanced non-small-cell lung cancer treated with pembrolizumab: Results from the phase i KEYNOTE-001 study
Journal:Journal of Clinical Oncology
Garon, Edward B.Hellmann, Matthew D.Rizvi, Naiyer A.Carcereny, EnricLeighl, Natasha B.Ahn, Myung JuEder, Joseph PaulBalmanoukian, Ani S.Aggarwal, CharuHorn, LeoraPatnaik, AmitaGubens, MatthewRamalingam, Suresh S.Felip, EnriquetaGoldman, Jonathan W.Scalzo, CathieJensen, ErinKush, Debra A.Hui, Rina
2019
 
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042
Proceeding/Conference:JTO Clinical and Research Reports
Mansfield, Aaron S.Herbst, Roy S.de Castro, GilbertoHui, RinaPeled, NirKim, Dong WanNovello, SilviaSatouchi, MiyakoWu, Yi LongGaron, Edward B.Reck, MartinRobinson, Andrew G.Samkari, AymanPiperdi, BilalEbiana, VictoriaLin, JianxinMok, Tony S.K.
2021
 
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Journal:The Lancet Oncology
Garassino, Marina C.Gadgeel, ShirishEsteban, EmilioFelip, EnriquetaSperanza, GiovannaDomine, ManuelHochmair, Maximilian J.Powell, StevenCheng, Susanna Yee ShanBischoff, Helge G.Peled, NirReck, MartinHui, RinaGaron, Edward B.Boyer, MichaelWei, ZiwenBurke, ThomasPietanza, M. CatherineRodríguez-Abreu, Delvys
2020
 
Pembrolizumab for the treatment of non-small-cell lung cancer
Journal:New England Journal of Medicine
Garon, Edward B.Rizvi, Naiyer A.Hui, RinaLeighl, NatashaBalmanoukian, Ani S.Eder, Joseph PaulPatnaik, AmitaAggarwal, CharuGubens, MatthewHorn, LeoraCarcereny, EnricAhn, Myung JuFelip, EnriquetaLee, Jong SeokHellmann, Matthew D.Hamid, OmidGoldman, Jonathan W.Soria, Jean CharlesDolled-Filhart, MarisaRutledge, Ruth Z.Zhang, JinLunceford, Jared K.Rangwala, ReshmaLubiniecki, Gregory M.Roach, CharlotteEmancipator, KennethGandhi, Leena
2015
 
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
Journal:The Lancet Respiratory Medicine
Leighl, Natasha B.Hellmann, Matthew D.Hui, RinaCarcereny, EnricFelip, EnriquetaAhn, Myung JuEder, Joseph PaulBalmanoukian, Ani S.Aggarwal, CharuHorn, LeoraPatnaik, AmitaGubens, MatthewRamalingam, Suresh S.Lubiniecki, Gregory M.Zhang, JinPiperdi, BilalGaron, Edward B.
2019
 
Updated analysis from KEYNOTE-189: Pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non–small-cell lung cancer
Journal:Journal of Clinical Oncology
Gadgeel, ShirishRodríguez-Abreu, DelvysSperanza, GiovannaEsteban, EmilioFelip, EnriquetaDómine, ManuelHui, RinaHochmair, Maximilian J.Clingan, PhilipPowell, Steven F.Yee-Shan Cheng, SusannaBischoff, Helge G.Peled, NirGrossi, FrancescoJennens, Ross R.Reck, MartinGaron, Edward B.Novello, SilviaRubio-Viqueira, BelénBoyer, MichaelKurata, TakayasuGray, Jhanelle E.Yang, JingBas, TubaPietanza, M. CatherineGarassino, Marina C.
2020
Showing results 1 to 6 of 6